INDOL-3-CARBINOL IN THE TREATMENT OF BENIGN BREAST DISORDERS
123 patients with various forms of fibrocystic mastopathy (n=114) and fibroadenoma of mammry gland (n=9) were enrolled into the study. Indol-3-carbinol (indinol, Close corporation «Mirax-Pharma») was administered in the dose of 300—400 mg per day for 3—6 months. Disappearance of complaints to pain w...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2014-09-01
|
| Series: | Opuholi Ženskoj Reproduktivnoj Sistemy |
| Online Access: | https://ojrs.abvpress.ru/ojrs/article/view/364 |
| Summary: | 123 patients with various forms of fibrocystic mastopathy (n=114) and fibroadenoma of mammry gland (n=9) were enrolled into the study. Indol-3-carbinol (indinol, Close corporation «Mirax-Pharma») was administered in the dose of 300—400 mg per day for 3—6 months. Disappearance of complaints to pain was observed in 35% of patients after 3 months of therapy and in 63% — after 6 months of therapy. Objective signs of fibrocystic mastopathy completely regressed in 9% of patients after 3 months of therapy and in 16% — after 6 month of therapy. Overall considerable improvement of condition or complete cure was seen in 55% of patients after 3 month of treatment and in 92% — after 6 months of therapy. Thus, indinol is highly effective and safe agent for treatment of different types of mastopathy. |
|---|---|
| ISSN: | 1994-4098 1999-8627 |